Published in Br J Addict on November 01, 1991
The measurement of drug craving. Addiction (2000) 3.64
Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction (2011) 2.58
Menstrual phase effects on smoking relapse. Addiction (2008) 2.33
A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychol Bull (2009) 2.08
The tobacco epidemic in Syria. Tob Control (2006) 2.06
Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol (2007) 1.94
Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry (2009) 1.91
The early time course of smoking withdrawal effects. Psychopharmacology (Berl) (2006) 1.90
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol (2014) 1.82
Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res (2009) 1.76
Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology (Berl) (2004) 1.75
Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.74
Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology (Berl) (2005) 1.70
In the trenches of real-world self-control: neural correlates of breaking the link between craving and smoking. Psychol Sci (2011) 1.63
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol (2006) 1.59
The clinical significance of drug craving. Ann N Y Acad Sci (2011) 1.54
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry (2009) 1.53
Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology (Berl) (2005) 1.45
Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol Psychiatry (2008) 1.43
Using SMS text messaging to assess moderators of smoking reduction: Validating a new tool for ecological measurement of health behaviors. Health Psychol (2011) 1.39
Evaluation of cue reactivity in the natural environment of smokers using ecological momentary assessment. Exp Clin Psychopharmacol (2009) 1.39
Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull (2011) 1.37
Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology (Berl) (2006) 1.37
Light and intermittent cigarette smokers: a review (1989-2009). Psychopharmacology (Berl) (2009) 1.31
Reactivity to nicotine cues over repeated cue reactivity sessions. Addict Behav (2007) 1.31
Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers. Addict Biol (2011) 1.30
Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol (2010) 1.30
Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function. Behav Pharmacol (2009) 1.29
Efficacy of attention bias modification using threat and appetitive stimuli: a meta-analytic review. Behav Ther (2012) 1.29
Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. Drug Alcohol Depend (2009) 1.29
Investigating the factor structure of the Questionnaire on Smoking Urges-Brief (QSU-Brief). Addict Behav (2005) 1.28
Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers. Psychopharmacology (Berl) (2007) 1.28
Effects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smoking. J Appl Behav Anal (2007) 1.22
Effects of nicotine deprivation on craving response covariation in smokers. J Abnorm Psychol (2003) 1.21
Quitting-unmotivated and quitting-motivated cigarette smokers exhibit different patterns of cue-elicited brain activation when anticipating an opportunity to smoke. J Abnorm Psychol (2011) 1.21
Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacology (Berl) (2005) 1.20
Hormonal, cardiovascular, and subjective responses to acute stress in smokers. Psychopharmacology (Berl) (2008) 1.19
Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology. Nicotine Tob Res (2008) 1.18
Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl) (2007) 1.18
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. J Appl Behav Anal (2008) 1.17
Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. Brain Imaging Behav (2007) 1.17
Prospective analysis of early lapse to drinking and smoking among individuals in concurrent alcohol and tobacco treatment. Psychol Addict Behav (2011) 1.16
Is the ten-item Questionnaire of Smoking Urges (QSU-brief) more sensitive to abstinence than shorter craving measures? Psychopharmacology (Berl) (2009) 1.14
Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods. Cancer Epidemiol Biomarkers Prev (2009) 1.13
The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect, and smoking behaviour: systematic review update and meta-analysis. Psychopharmacology (Berl) (2012) 1.13
The effects of cigarette smoking on script-driven imagery in smokers with and without posttraumatic stress disorder. Addict Behav (2007) 1.11
Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence. Psychopharmacology (Berl) (2009) 1.10
Anger and psychobiological changes during smoking abstinence and in response to acute stress: prediction of smoking relapse. Int J Psychophysiol (2007) 1.10
Evaluating oral noncombustible potential-reduced exposure products for smokers. Nicotine Tob Res (2010) 1.08
An acute psychosocial stress enhances the neural response to smoking cues. Brain Res (2009) 1.07
Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction. Neuropsychopharmacology (2011) 1.07
Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives: II. Evidence from a laboratory self-administration assay. J Abnorm Psychol (2010) 1.06
A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Exp Clin Psychopharmacol (2010) 1.06
Influence of the duration of abstinence on the relative reinforcing effects of cigarette smoking. Psychopharmacology (Berl) (2005) 1.06
Influence of phase-related variability in premenstrual symptomatology, mood, smoking withdrawal, and smoking behavior during ad libitum smoking, on smoking cessation outcome. Addict Behav (2008) 1.05
Measures for assessing subjective effects of potential reduced-exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Cue-reactors: individual differences in cue-induced craving after food or smoking abstinence. PLoS One (2010) 1.05
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. Schizophr Res (2007) 1.04
A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities. Am J Addict (2010) 1.04
Subjective effects of the nicotine lozenge: assessment of abuse liability. Psychopharmacology (Berl) (2003) 1.04
Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia. Drug Alcohol Depend (2011) 1.04
Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance. Tob Control (2003) 1.04
Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology (2010) 1.03
Using virtual reality to assess young adult smokers' attention to cues. Cyberpsychol Behav (2009) 1.02
Evidence for greater cue reactivity among low-dependent vs. high-dependent smokers. Addict Behav (2010) 1.02
Initial puffing behaviors and subjective responses differ between an electronic nicotine delivery system and traditional cigarettes. Tob Induc Dis (2014) 1.02
Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology (Berl) (2003) 1.01
Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcohol Clin Exp Res (2008) 1.00
Smoking- and menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptoms. Addict Behav (2014) 0.98
Smoking withdrawal in smokers with and without posttraumatic stress disorder. Nicotine Tob Res (2011) 0.98
Acute exercise modulates cigarette cravings and brain activation in response to smoking-related images: an fMRI study. Psychopharmacology (Berl) (2008) 0.97
Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia. Am J Psychiatry (2012) 0.97
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology (Berl) (2005) 0.97
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers. J Psychopharmacol (2012) 0.97
The PROMIS Smoking Initiative: initial validity evidence for six new smoking item banks. Nicotine Tob Res (2014) 0.97
Severity of withdrawal symptomatology in follicular versus luteal quitters: The combined effects of menstrual phase and withdrawal on smoking cessation outcome. Addict Behav (2010) 0.96
The impact of cigarette deprivation and cigarette availability on cue-reactivity in smokers. Addiction (2009) 0.96
Deconstructing craving: dissociable cortical control of cue reactivity in nicotine addiction. Biol Psychiatry (2011) 0.96
Subjective reactivity to smoking cues as a predictor of quitting success. Nicotine Tob Res (2011) 0.96
Subjective responses to intravenous nicotine: greater sensitivity in women than in men. Exp Clin Psychopharmacol (2009) 0.96
Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers. J Behav Med (1999) 0.94
Temporal and probability discounting by cigarette smokers following acute smoking abstinence. Nicotine Tob Res (2012) 0.94
Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol (2009) 0.94
Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use. Drug Alcohol Depend (2012) 0.94
Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol Clin Exp Res (2012) 0.93
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Curr Drug Abuse Rev (2014) 0.92
Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res (2013) 0.92
Effects of nicotine withdrawal on verbal working memory and associated brain response. Psychiatry Res (2010) 0.92
Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers. Am J Psychiatry (2013) 0.92
Severity of tobacco abstinence symptoms varies by time of day. Nicotine Tob Res (2009) 0.92
The effects of exercise on cigarette cravings and brain activation in response to smoking-related images. Psychopharmacology (Berl) (2012) 0.92
A comprehensive study of sensorimotor cortex excitability in chronic cocaine users: Integrating TMS and functional MRI data. Drug Alcohol Depend (2015) 0.91
Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers. Nicotine Tob Res (2010) 0.91
Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans. Neuropsychopharmacology (2013) 0.91
Estimating demand for alternatives to cigarettes with online purchase tasks. Am J Health Behav (2014) 0.91
A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav (2013) 0.91
Human nicotine conditioning requires explicit contingency knowledge: is addictive behaviour cognitively mediated? Psychopharmacology (Berl) (2005) 0.91
Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine Tob Res (2015) 0.90
Effect of glucose on tobacco craving. Is it mediated by tryptophan and serotonin? Psychopharmacology (Berl) (2004) 0.90
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev (1990) 6.46
Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry (2001) 2.23
Imagery and smoking urges: the manipulation of affective content. Addict Behav (1990) 1.42
Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators. Genes Brain Behav (2009) 0.96
Neuroimaging in alcoholism: ethanol and brain damage. Alcohol Clin Exp Res (2001) 0.93
Differential urge and salivary responsivity to alcohol cues in alcohol-dependent patients: a comparison of traditional and stringent classification approaches. Exp Clin Psychopharmacol (1999) 0.84
The application of 1980s psychology to 1990s smoking research. Br J Addict (1991) 0.82
Contribution of associative and nonassociative processes to the development of morphine tolerance. Psychopharmacology (Berl) (1992) 0.77
Effect of interdose interval on the development of associative tolerance to morphine in the rat: a dose-response analysis. Behav Neurosci (1991) 0.76
CHRNA5 variants moderate the effect of nicotine deprivation on a neural index of cognitive control. Genes Brain Behav (2014) 0.76